This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To review the clinical effectiveness and safety of haloperidol compared with risperidone for people with schizophrenia.
CITATION STYLE
Ray, S., Ray, A., Gopi, A., & Hunter, R. (2017). Haloperidol versus risperidone for schizophrenia. Cochrane Database of Systematic Reviews, 2017(7). https://doi.org/10.1002/14651858.CD012728
Mendeley helps you to discover research relevant for your work.